Excess liabilities at Exora Medical
First written in FY2021. . Latest entry: FY2026.
The whole theme swung hardest in 2020: 18 of 46 companies on the "Worse" side.
36 other companies' latest entry also says "Other".
- FY2026Growing excess liabilities and continued dormancyAnnual report
「The company has negative net worth, amounting to ¥243.979 million as of 30 June 2026. Its business is currently dormant.」
エクソーラメディカル's negative net worth increased from ¥237.373 million in the previous fiscal year to ¥243.979 million, and its business remains dormant. - FY2024Growing excess liabilities and continued dormancyAnnual report
「The company has negative net worth, amounting to ¥237.373 million as of 30 June 2024. Its business is currently dormant.」
エクソーラメディカル's negative net worth increased from ¥234.629 million in the previous fiscal year to ¥237.373 million, and its business remains dormant. - FY2023Increase in negative net worth and continued dormancyAnnual report
「The company has negative net worth, amounting to ¥234.629 million as of 30 June 2023. Its business is currently dormant.」
エクソーラメディカル's negative net worth increased from ¥231.810 million in the previous fiscal year to ¥234.629 million, and the company disclosed that its business is currently dormant. - FY2022Increase in Excess LiabilitiesAnnual report
「The company has negative net worth, with the deficit amounting to ¥231.810 million as of 30 June 2022.」
エクソーラメディカル's negative net worth increased from ¥227.950 million in the previous fiscal year to ¥231.810 million. - FY2021First statedAnnual report
「The company has negative net worth, with the deficit amounting to ¥227.950 million as of the end of June 2021.」
The company disclosed for the first time that its consolidated subsidiary エクソーラメディカル had negative net worth of ¥227.950 million as of the end of June 2021.